Known targets — ChEMBL curated mechanism
ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG
The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE known ✓ | P22303 | 7/20 | 0.36 |
| ▸ | BCHE | P06276 | 7/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.33 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.33 |
| ▸ | INMT | O95050 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL666882 | 0.98 | BCHE (0.37) | BCHEACHEKDM4ENPC1PABPC1 | |
| Hydrochloric Acid SCHEMBL384461 | 0.96 | BCHE (0.36) | BCHEACHEINMTNPSR1L3MBTL1 | |
| Bromide SCHEMBL20531183 | 0.96 | BCHE (0.36) | BCHEACHEINMTNPSR1L3MBTL1 | |
| SCHEMBL29623928 | 0.90 | BCHE (0.33) | BCHEACHEINMT | |
| SCHEMBL384826 | 0.90 | ACHE (0.33) | BCHEACHE | |
| Iodide SCHEMBL2535719 | 0.89 | BCHE (0.31) | BCHEACHE | |
| Phosphoric Acid SCHEMBL20531176 | 0.87 | CA2 (0.33) | BCHEACHEL3MBTL1 | |
| Phosphoric Acid SCHEMBL20531175 | 0.87 | TSHR (0.33) | BCHEACHE | |
| SCHEMBL3628120 | 0.87 | BCHE (0.32) | BCHEACHE | |
| Cyanate SCHEMBL29623811 | 0.87 | BCHE (0.32) | BCHEACHEL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12534485-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2026-01-27 | — | — | US | disclosed |
| US-20250127030-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2025-04-17 | — | — | US | disclosed |
| US-12171138-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2024-12-17 | — | — | US | disclosed |
| US-20220328774-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2022-10-13 | — | — | US | disclosed |
| CN-115160374-A | Stable OLED materials and devices with improved stability | 通用显示公司 | 2022-10-11 | — | — | CN | disclosed |
| US-11404650-B2 | Stability OLED materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2022-08-02 | — | — | US | disclosed |
| US-20220169670-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2022-06-02 | — | — | US | disclosed |
| CN-113024612-A | Metal complexes comprising azaborine carbene ligands and their use in OLEDs | 北京八亿时空液晶科技股份有限公司 | 2021-06-25 | — | — | CN | disclosed |
| CN-108409797-B | Organic metal complex, preparation method and application thereof | 瑞声光电科技(常州)有限公司 | 2020-09-01 | — | — | CN | disclosed |
| US-20190326524-A1 | ORGANIC METAL COMPLEX, PREPARATION METHOD AND APPLICATION THEREOF | NANGJING TECH UNIVERSIY (CN) | 2019-10-24 | — | — | US | disclosed |
| US-20130178621-A1 | PROCESS FOR PREPARING TRANSITION METAL-CARBENE COMPLEXES | BASF SE (DE) | 2013-07-11 | — | — | US | disclosed |
| US-8410280-B2 | Process for preparing transition metal-carbene complexes | BASF SE (DE) | 2013-04-02 | — | — | US | disclosed |
| US-7902374-B2 | Stability OLED materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2011-03-08 | — | — | US | disclosed |
| EP-1878053-B1 | STABILITY OLED MATERIALS AND DEVICES WITH IMPROVED STABILITY | UNIVERSAL DISPLAY CORP (US) | 2009-08-26 | — | — | EP | disclosed |
| US-20090018330-A1 | PROCESS FOR PREPARING TRANSITION METAL-CARBENE COMPLEXES | BASF SE (DE) | 2009-01-15 | — | — | US | disclosed |
| WO-2008054584-A1 | IMPROVED STABILITY OLED MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2008-05-08 | — | — | WO | disclosed |
| EP-1878053-A1 | STABILITY OLED MATERIALS AND DEVICES WITH IMPROVED STABILITY | Universal Display Corporation (US) | 2008-01-16 | — | — | EP | disclosed |
| US-20070088167-A1 | Stability OLED materials and devices | UNIVERSAL DISPLAY CORPORATION | 2007-04-19 | — | — | US | disclosed |
| WO-2006121811-A1 | STABILITY OLED MATERIALS AND DEVICES WITH IMPROVED STABILITY | UNIVERSAL DISPLAY CORPORATION (US) | 2006-11-16 | — | — | WO | disclosed |
| US-20060251923-A1 | Stability OLED materials and devices | UNIVERSAL DISPLAY CORPORATION | 2006-11-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190326524-A1 | ORGANIC METAL COMPLEX, PREPARATION METHOD AND APPLICATION THEREOF | INTS9, INTS6, PICALM | ACHE 2364/4885BCHE 4527/4885KDM4E 3442/4885 |
| US-20090018330-A1 | PROCESS FOR PREPARING TRANSITION METAL-CARBENE COMPLEXES | AP1M1, C1S, GPS1 | ACHE 2375/4885BCHE 2243/4885KDM4E 4586/4885 |
| US-20220328774-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OSBP2, EML4, OSBP | ACHE 750/4885BCHE 3533/4885KDM4E 3622/4885 |
| US-11404650-B2 | Stability OLED materials and devices | OCIAD2, OCIAD1, OSBP2 | ACHE 1738/4885BCHE 4132/4885KDM4E 3914/4885 |
| US-12534485-B2 | Organic electroluminescent materials and devices | LBR, GLRB, GLRA3 | ACHE 3796/4885BCHE 2965/4885KDM4E 4013/4885 |
| US-20220169670-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | ICOSLG, OCIAD1, OCIAD2 | ACHE 537/4885BCHE 1562/4885KDM4E 3440/4885 |
| US-20250127030-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OSBP2, EML4, OSBP | ACHE 753/4885BCHE 3547/4885KDM4E 3625/4885 |
| US-20130178621-A1 | PROCESS FOR PREPARING TRANSITION METAL-CARBENE COMPLEXES | AP1M1, C1S, GPS1 | ACHE 2375/4885BCHE 2243/4885KDM4E 4586/4885 |
| US-12171138-B2 | Organic electroluminescent materials and devices | OSBP2, EML4, OSBP | ACHE 750/4885BCHE 3533/4885KDM4E 3622/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.